Significance of combination of serum C1q antibody,interleukin-18,C3 and C4 in lupus nephritis

CLINICAL FOCUS ›› 2010, Vol. 25 ›› Issue (8): 676-679.

Previous Articles Next Articles

Significance of combination of serum C1q antibody,interleukin-18,C3 and C4 in lupus nephritis

HAN Zhi-jie;ZHU Yun;ZHANG Qun-qun;LI Ming

Online:2010-04-20 Published:2010-04-20

Abstract

CLC Number:

R593.24

HAN Zhi-jie;ZHU Yun;ZHANG Qun-qun;LI Ming. Significance of combination of serum C1q antibody,interleukin-18,C3 and C4 in lupus nephritis[J]. CLINICAL FOCUS, 2010, 25(8): 676-679.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/

https://huicui.hebmu.edu.cn/EN/Y2010/V25/I8/676

[1]	Qin Meijie, Tian Maolu, Yang Yuqi, Zha Yan, Yuan Jing. Literature review on treatment of immune thrombocytopenia secondary to refractory systemic lupus erythematosus with belimumab combined with cyclosporine: A case report and literature review [J]. Clinical Focus, 2022, 37(6): 544-547.
[2]	. [J]. Clinical Focus, 2021, 36(2): 174-178.
[3]	. [J]. Clinical Focus, 2015, 30(9): 1066-1069.
[4]	Gao Yuan;Meng Qinghua;Liu Haixia;Zhu Yueke. Abnormal liver function as the first symptom of systemic lupus erythematosus: analysis of 15 cases [J]. Clinical Focus, 2015, 30(7): 806-810.
[5]	Li Wenru;Xing Guangqun. Effect of contact system and neutrophil extracellular traps in pathogenesis of lupus nephritis [J]. Clinical Focus, 2015, 30(6): 653-656.
[6]	HUANG Zhi-fang;LI Xin-lun;LI Hong-xia;LUN Li-de. Efficacy and safety of intravenous immunoglobulin in severe systemic lupus erythematosus [J]. Clinical Focus, 2014, 29(11): 1243-1245.
[7]	. [J]. Clinical Focus, 2014, 29(9): 1066-1067.
[8]	LI Hong-bo;ZHANG Jing-kun;WU Chao;WANG Ji;ZHANG Yu-jun;GAO Li-xia. Relationship of high mobility group protein 1,Toll-like receptors 4, vascular endothelial cell adhesion molecule-1 expression in lupus nephritis with dyslipidemia [J]. Clinical Focus, 2014, 29(8): 891-895.
[9]	. [J]. CLINICAL FOCUS, 2014, 29(3): 357-0.
[10]	. [J]. CLINICAL FOCUS, 2013, 28(10): 1179-1181.
[11]	. [J]. CLINICAL FOCUS, 2013, 28(9): 1059-1060.
[12]	WANG Zeng-ling;XING Guang-qun;LI Chun-mei. Level and significance of serum peptidylarginine deiminase type 4 in patients with systemic lupus erythematous [J]. Clinical Focus, 2013, 28(5): 515-518.
[13]	XU Xiao-ling;YU Xuan-hua;LI Yi-nong. Levels and clinical significance of B cell activating factor and interferon-α in systemic lupus erythematosus [J]. Clinical Focus, 2013, 28(5): 522-524532.
[14]	DUAN Ji-hui;JIANG Yan;MU Hong;TANG Zhi-qin;JIANG Jie-chun. Expression of TACI in patients with lupus nephritis [J]. Clinical Focus, 2013, 28(2): 141-143147.
[15]	. [J]. Clinical Focus, 2013, 28(1): 103-104.

Significance of combination of serum C1q antibody,interleukin-18,C3 and C4 in lupus nephritis

Knowledge

Cited

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments